Skip to Content

Clinical Trial Details

A Phase III Trial Evaluating the Addition of Trastuzumab to Trimodality Treatment of HER2-Overexpressing Esophageal Adenocarcinoma

IRB Protocol Number
RTOG 1010

Clinical Trial Categories

  • Esophageal
Contact
Barbara Beauchemin, RN, BSN at 603-224-2556

Location

  • Payson Center for Cancer Care
    250 Pleasant Street
    Concord, NH 03301
    Main: 603-230-6000